Australians will soon have more options when it comes to daily contact lenses following the launch of Johnson and Johnson’s Acuvue Oasys Max 1-Day contact lenses (CLs) and Acuvue Oasys Max 1-Day multifocal CLs.
With adults spending an average of 13+ hours looking at screens daily,1 placing increasing demand on our eyes, Johnson and Johnson said the lenses arrive at a pivotal time.
Described as “an unprecedented combination of new technologies” that provide “reliable comfort and performance”, Acuvue Oasys Max 1-Day lenses are built with TearStable Technology to maximise tear-film stability and lock in moisture for exceptional all-day comfort,2 while an OptiBlue light filter with the highest level blue-violet light filter in the industry at 60%‡,3 helps reduce light scatter and increase visual clarity, day and night. Additionally, Acuvue Oasys Max 1-Day lenses block 99.9% UVA rays and 100% UVB rays.††,§§,4,5
Michelle Ho, Business Unit Director, Vision, Johnson and Johnson, Australia and New Zealand said there is “a huge need for innovation like Acuvue Oasys Max 1-Day, that has been informed by wearers and eye care professionals, priming it to keep up with the lifestyles of all Australians, and address eye strain as a result of longer days and increased time looking at digital devices”.
Johnson and Johnson said the lenses arrive at a pivotal time.
Presbyopia Solution
For patients with presbyopia, Johnson and Johnson claims its new Acuvue Oasys Max 1-Day multifocal CLs provide crisp, clear vision at all distances and in all lighting conditions, as well as all-day comfort.7 The lenses combine the same two powerful technologies – TearStable Technology and the OptiBlue light filter – plus Pupil Optimised Design technology, which tailors 100% of parameters to pupil size variations across both age and refraction compared to less than 2% for the leading competitor, for exceptionally effortless vision.§,6 This is the same technology that is available across all Acuvue Multifocal CLs.7
Building on an Unbeaten Portfolio
Acuvue Oasys Max 1-Day builds on the Acuvue Oasys portfolio of products, which is unbeaten in comfort across 29 clinical studies.‡‡ In clinical trials of Acuvue Oasys Max 1-Day, nearly 90% of wearers reported all-day comfort and a reduction in tired eyes from digital devices, and nearly 100% agreed the lenses provided clear, reliable vision.2
The lenses will be available to wearers in Australia from 1 July 2024.
‡ Versus publicly available knowledge as of December 2023.
†† Helps protect against transmission of harmful UV radiation to the cornea and into the eye.
§ Warning: UV-absorbing contact lenses are the NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. Wearers should continue to use UV-absorbing eyewear as directed. Note: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.
§ Compared to competitor’s designs, technology optimised for both the parameters of refractive error and add power.
‡‡ ClinicalTrials.gov is a website maintained by the NIH. The 29 clinical studies evaluated subjective comfort as a primary or secondary endpoint for Acuvue Oasys brand 2-week family, Acuvue Oasys 1-Day Brand family, and Acuvue Oasys Max 1-Day brand family of contact lenses, vs. competitors’ products. Review conducted as of April 2024.
References
- Eyesafe estimate based upon Nielsen Q3 2019 Total Audience Report. Available at:eyesafe.com/covid-19-screen-time-spike-to-over-13-hours-per-day.
- JJV data on file, 2022. CSM subjective responses Acuvue Oasys Max 1-Day contact lenses: retrospective meta-analysis.
- JJV data on file 2022. TearStable technology definition.
- JJV data on file Material properties: 1-Day Acuvue Moist, 1-Day Acuvue Trueye, Acuvue Oasys 1-Day with HydraLuxe technology and Acuvue Oasys Max 1-Day with TearStable technology brand contact lenses.
- JJV data on file 2022: Master brand claims on clinical performance and overall material properties for Acuvue brand soft contact lenses.
- JJV data on file 2022. Subjective stand-alone claims for Acuvue Oasys Max 1-Day multifocal contact lenses – exploratory meta-analysis.
- JJV data on file 2022. CSM: Acuvue Pupil Optimized Design technology: JJVC contact lenses, design features, and associated benefits.